IJCRR - Vol 11 Issue 07, April
Date of Publication: 12-Apr-2019
Download XML Download PDF
Inhibitory Action Against Alpha Glucosidase by Selected Dihydroxy Flavones
Author: S. Umamaheswari, K. S. Sridevi Sangeetha
Abstract:Background: Diabetes is one of the common metabolic disorder that occurs due to poor secretion of insulin. It is more common among aged people in India. The incidence of diabetes is increasing every day and this indicates the increasing need for the treatment for diabetes.
Objective: The objective of the present study is to screen the effects of selected substituted dihydroxyflavone for its in vitro antidiabetic effect by finding the potential to inhibit the enzymes \a-Glucosidase.
Materials and Methods: The dihydroxy flavones used in the present study includes 2',3'- dihydroxy flavone and 2', 4' dihydroxy flavones. They were synthesized using standard procedures. In vitro \a-glucosidase inhibitory activity was evaluated by Li et al., 2004. The different concentration of the flavonoid ( 0.1, 0.3, 1, 3,10, 30, 100, 300, 1000 (\?M/ml) were used and the experiment was done for triplicate sample. The standard antidiabetic drug used in the study was Acarbose. The inhibitory activity was calculated and tabulated.
Results: The selected Dihydroxy flavones 2',3'- dihydroxy flavone and 2', 4' dihydroxy flavones showed significant invitro anti diabetic activity when compared with standard drug acarbose. The IC50 value of 2',3'- dihydroxy flavones and 2', 4' dihydroxy flavones was found to be 0.47\?M/ml, 46.37 \?M/ml respectively.
Keywords: Diabetes, Dihydroxy flavones, in vitro, Alpha glucosidase, Metabolic disorder
DOI URL: http://dx.doi.org/10.31782/IJCRR.2019.0508
Diabetes is often called the silent killer because people who have it are often unaware they are affected. It is one of the oldest and most prevalent chronic non-communicable disease. Diabetes Mellitus is characterized by hyperglycemia, impaired metabolism of lipids, carbohydrates and proteins with an increased risk of complication related to vascular diseases. The minimum defining feature to identify diabetes mellitus is the chronic and substantiated rise in circulating glucose concentration. The normal level of blood sugar in a fasting person is between 80-120mg percent. If the fasting level of blood sugar is more than 110mg percent or after meals more than 160mg percent, it is called high blood sugar (Diabetes Mellitus). In diabetic patients, sugar can be detected in the urine also. Patients with diabetes have a higher chance of development of coronary blockages. They also get several other diseases like kidney damages as well as damage to the nerves and eyes1-3.
According to an estimation of the International Diabetes Federation, approximately 366 million people are suffering from diabetes and this may double by 2030, in India to be 40.9 million, which is expected to grow to 60.9 million by 20254.
This can also be characterized by a state of chronic hyperglycemia, glucosuria, polyurea, polydipsia, polyphagia sudden weight loss, ketoacidosis and ketonuria. In type 1 diabetes, the pancreas fails to produce insulin. Because insulin transports sugar into cells, when a body lacks insulin, its cells starve for energy. In type 2 diabetes, there is plenty of insulin in the body, but sugar still cannot get inside the cells. In both types of diabetes, sugar in the blood becomes very high. Type 2 is more prevalent than type 1, with more than 90% of the total diabetic patients suffering from it. Postprandial hyperglycemia plays an important role in the development of T2D5.
Number of environmental factors act on genetically susceptible individuals. They includes Sedentary life style, Diet, Malnutrition, Viral Infections, Chemical agents and Stress.
Diabetes is generally accepted as a major challenging health problem all over the world and especially in the developing countries. India has the dubious distinction of being home to one in five persons with diabetes world. The World Health Organization (WHO) predicts that the number of people with diabetes is to double in the next couple of decades and that the major burnt of this will be borne by the developing countries6.
The management of Diabetes Mellitus is considered as a global problem whose successful treatment is yet to be discovered. Insulin is widely accepted as an ideal choice for treatment of diabetes mellitus but the difficulty of repeated administration led to the search for the hypoglycemic agents.
Chronic hyperglycemia has been considered as one of the principal causes for several diabetic complications. In patients with Type II diabetes, postprandial blood glucose is elevated due to absorption of glucose from the gastrointestinal tract. The major enzyme involved in carbohydrates digestion is α-glucosidase (Figure-1), it is present in the brush borders of small intestine. It plays a vital role in preventing postprandial rise in blood glucose, this is because Inhibition of these enzyme systems helps to reduce the rate of digestion of carbohydrates and reduces the rate of glucose absorption from the gut and finally lowers the postprandial rise in blood glucose level7-9. Therefore, inhibition of α-glucosidase is a key in the management and treatment of Type II diabetes10,11. Alpha glucosidase inhibitors are used as oral anti diabetic drugs for treating type 2 diabetes mellitus12,13.
Flavonoids are the largest group of naturally occurring poly phenolic compounds present almost in all parts of flowering plants. Flavones have reported to have interesting pharmacological action such as anti-oxidant, anti-inflammatory, antihepatotoxic, anti-microbial, anticarcinogenic The combination of multiple pharmacological properties in a single nucleus is quite interesting.
In a previous study done by the authors, it has been proven that the selected dihydroxyflavones 2’,3’- dihydroxy flavone and 2’, 4’ dihydroxy flavones have potent antinociceptive14 and anti-inflammatory action 15. In the present study an attempt was done to screen the effects of selected substituted dihydroxyflavone for its in vitro antidiabetic effect by finding the potential to inhibit the enzymes α-Glucosidase.
Material and Methods:
α-glucosidase and 3, 5, di-nitro salicylic acid (DNS) were purchased from Sigma-Aldrich, Bangalore. P-nitro-phenyl-α-D-glucopyranoside (p-NPG), sodium carbonate (Na2 CO3), sodium dihydrogen phosphate, di-sodium hydrogen phosphate were purchased from Hi-Media, Mumbai.
The dihydroxy flavones used in the present study includes 2’,3’- dihydroxy flavone and 2’, 4’ dihydroxy flavones, they were synthesized using standard procedures at Research Organics, Chennai, India. The authenticities of these compounds were done with melting points and UV method.
In vitro α-glucosidase inhibitory activity was evaluated by Li et al., 2004. α-Glucosidase inhibitory assay is based on the breakdown of maltose to glucose. 200 μl of α -glucosidase solution was pre-incubated with the test and control samples for 5 min. The reaction was started by adding 200 μl of sucrose and it was terminated after 30 min incubation at 370C by heating at 90–1000C. The liberated glucose was determined. The enzyme activity is directly proportional to the liberated glucose and the liberated glucose is measured by GOD-POD method at 546nm using semi auto analyzer. The different concentration of the flavonoid ( 0.1, 0.3, 1, 3,10, 30, 100, 300, 1000 (μM/ml) were used and the experiment was done for triplicate sample. The standard antidiabetic drug used in the study was Acarbose. The inhibitory activity of the compounds was calculated as follows
% Inhibition= [(control-test)/control)] X 100
All the measurements were done in triplicate and results are expressed in terms of mean ± standard deviation and IC50 values were calculated using Graph Pad Prism version 5.01.
Results and discussions:
One of the therapeutic approaches for preventing diabetes mellitus is to decrease the absorption of glucose through inhibition of α-glucosidase, which is a carbohydrates digesting enzymes, located in the brush borders of the small intestine. Determining the In vitro α-glucosidase inhibitory activity was found to be one of the important tool used to examine the antidiabetic effect of any compound. The Percentage α-glucosidase inhibition was calculated for 2’,3’- dihydroxy flavone and 2’, 4’ dihydroxy flavone at various concentration 1, 0.3, 1, 3,10, 30, 100, 300, 1000 (μM/ml)and presented in Table 1. Standard drug used here is acarbose. The Inhibitory concentration IC50 was calculate using graph pad prism software. The selected Dihydroxy flavones 2’,3’- dihydroxy flavone and 2’, 4’ dihydroxy flavone showed significant In vitro α-glucosidase inhibitory activity when compared with standard drug acarbose. The IC50 value of 2’,3’- dihydroxy flavones and 2’, 4’ dihydroxy flavones was found to be 0.47μM/ml, 46.37 μM/ml respectively.
Table 1: In vitro α-glucosidase inhibitory activity of 2’,3’- dihydroxy flavone , 2’, 4’ dihydroxy flavone and the standard drug ( acarbose)
The present study showed that 2’,3’- dihydroxy flavone and 2’, 4’ dihydroxy flavones moderately inhibit α-glucosidase activity. Out of the two compounds 2’, 3’ dihydroxy flavones have excellent invitro antidiabetic effect in α-Glucosidase inhibitory model, hence it can be used as oral antidiabetic drug. Further preclinical evaluation studies are needed to confirm its action on postprandial hypoglycemic effect.
Conclusion: The study reveal that 2’, 3’ dihydroxy flavones have excellent in vitro antidiabetic effect in α-Glucosidase inhibitory assay model.
Source of Funding: Nil
Conflict of interest: Nil
Authors’ Contribution: First author involved in the experimentation and analysis of work. The second author contributed in writing part of the study.
Acknowledgment: The author wish to thank the management of Sri Ramachandra Institute of Higher Education and Research for the encouragement and support.
American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes care. 2018 Jan 1;41(Supplement 1):S13-27.
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology. 2018 Feb;14(2):88.
Ramachandran A, Snehalatha C. Current scenario of diabetes in India. Journal of diabetes. 2009 Mar;1(1):18-28.
Mitra A, Dewanjee D, Dey B. Mechanistic studies of lifestyle interventions in type 2 diabetes. World journal of diabetes. 2012 Dec 15;3(12):201.
Matyka KA. Type 2 diabetes in childhood: epidemiological and clinical aspects. British medical bulletin. 2008 Jun 1;86(1):59-75.
Tiwari AK, Rao JM. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Current science. 2002 Jul 10:30-8.
Matsui T, Tanaka T, Tamura S, Toshima A, Tamaya K, Miyata Y, Tanaka K, Matsumoto K. α-Glucosidase inhibitory profile of catechins and theaflavins. Journal of Agricultural and Food Chemistry. 2007 Jan 10;55(1):99-105.
Kim YM, Jeong YK, Wang MH, Lee WY, Rhee HI. Inhibitory effect of pine extract on α-glucosidase activity and postprandial hyperglycemia. Nutrition. 2005 Jun 1;21(6):756-61.
Chipiti T, Ibrahim MA, Singh M, Islam MS. In vitro α-amylase and α-glucosidase Inhibitory and Cytotoxic Activities of Extracts from Cissus cornifolia Planch Parts. Pharmacognosy magazine. 2017 Jul;13(Suppl 2):S329.
Kumar S, Narwal S, Kumar V, Prakash O. α-glucosidase inhibitors from plants: A natural approach to treat diabetes. Pharmacognosy reviews. 2011 Jan;5(9):19.
Nair SS, Kavrekar V, Mishra A. In vitro studies on alpha amylase and alpha glucosidase inhibitory activities of selected plant extracts. European Journal of Experimental Biology. 2013;3(1):128-32.
Li Y, Peng G, Li Q, Wen S, Huang TH, Roufogalis BD, Yamahara J. Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese Zucker rats. Life sciences. 2004 Aug 20;75(14):1735-46.
Telagari M, Hullatti K. In-vitro α-amylase and α-glucosidase inhibitory activity of Adiantum caudatum Linn. and Celosia argentea Linn. extracts and fractions. Indian journal of pharmacology. 2015 Jul;47(4):425.
Umamaheswari S, Viswanathan S, Sathiyasekaran BW, Parvathavarthini S, Ramaswamy S. Antinociceptive activity of certain dihydroxy flavones. Indian journal of pharmaceutical sciences. 2006;68(6):749.
Umamaheswari S, Sangeetha KS. Anti-Inflammatory Effect of Selected Dihydroxyflavones. Journal of clinical and diagnostic research: JCDR. 2015 May;9(5):FF05.